Pon-1 - OmicsDI

Show results for

Unknown (134)
Transcriptomics (26)
Metabolomics (16)
Proteomics (6)
Genomics (4)

Organisms

Homo sapiens (15)
Mus musculus (12)
Alphavirus (2)
Anemia (2)
Archaea (2)
Bacteria (2)
Betaherpesvirinae (2)
Borrelia (2)
Clostridium perfringens (2)
Cowpox virus (2)
Coxsackievirus (2)
Cytomegalovirus (2)
Dengue virus (2)
EFO:0001352 (2)
Hepatitis B virus (2)
Human alphaherpesvirus 1 (2)
Human betaherpesvirus 5 (2)
Human immunodeficiency virus (2)
Influenza A virus (2)
Influenza C virus (2)
Japanese encephalitis virus group (2)
Listeria monocytogenes (2)
Mammarenavirus (2)
Miscanthus x giganteus (2)
Mycobacterium tuberculosis (2)
Oropouche virus (2)
Rattus (2)
Streptococcus pneumoniae (1)
Rattus norvegicus (1)
Drosophila melanogaster (1)

Organisms

Homo sapiens (1)

Repository

biostudies-arrayexpress (27)
MetaboLights (16)
PanoramaPublic (3)
ENA (3)
pride (2)
MassIVE (1)

Tissue

Hepatoma cell line (1)
Malignant cell (1)

Disease

Liver cancer (1)

Technology Type

Mass spectrometry (13)
NMR spectroscopy (2)
Mass spectrometry assay (2)
Mass Spectrometry (2)
DiaPASEF (1)
Shotgun proteomics (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (10)
Liquid Chromatography MS - positive - reverse phase (9)
Liquid Chromatography MS - positive - hilic (3)
Illumina HiSeq 1500 (2)
Liquid Chromatography MS - Positive (LC-MS (Positive)) (2)
HISAT2, TOPHAT2 (1)
Illumina NovaSeq X (1)
Illumina HiSeq 2500 (1)
Illumina HiSeq 2000 (1)
Illumina HiSeq 3000 (1)
TripleTOF 5600 (1)
Liquid Chromatography MS - Negative (LC-MS (Negative)) (1)
Nuclear Magnetic Resonance (NMR) (1)
Liquid Chromatography Tandem MS (LC-MS/MS) (1)
Nuclear Magnetic Resonance (NMR) - (1)
Liquid Chromatography MS - alternating - reverse phase (1)

Publication Date

2021 (7)
2022 (6)
2019 (5)
2011 (5)
2025 (4)
2012 (4)
2015 (3)
2009 (3)
2023 (3)
2014 (2)
2013 (2)
2026 (1)
2016 (1)
2008 (1)

CHEBI ID

CHEBI:16196 (5)
CHEBI:16919 (5)
CHEBI:27897 (5)
CHEBI:17368 (5)
CHEBI:28044 (4)
CHEBI:17847 (4)
CHEBI:16040 (4)
CHEBI:46195 (4)
CHEBI:15891 (4)
CHEBI:15318 (4)
CHEBI:27823 (4)
CHEBI:16411 (4)
CHEBI:7916 (4)
CHEBI:46961 (4)
CHEBI:17568 (4)
CHEBI:16704 (4)
CHEBI:35280 (4)
CHEBI:156419 (3)
CHEBI:134583 (3)
CHEBI:172610 (3)
CHEBI:84372 (3)
CHEBI:142273 (3)
CHEBI:74450 (3)
CHEBI:18101 (3)
CHEBI:17625 (3)
CHEBI:17303 (3)
CHEBI:16244 (3)
CHEBI:17768 (3)
CHEBI:27570 (3)
CHEBI:30745 (3)

Metabolite Name

Deoxyuridine triphosphate (3)
Cytosine (3)
Butyrylcarnitine (3)
Oleic acid (3)
Uric acid (3)
Creatinine (3)
Creatine (3)
Hypoxanthine (3)
PI(16:0/18:2) (2)
PE(16:0/20:4) (2)
Pentagastrin (2)
PS(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (2)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (2)
PE(16:0/18:2) (2)
P-cresol (2)
2-Hydroxy-22-methyltetracosanoic acid (2)
Bortezomib (2)
3-Oxotetradecanoyl-CoA (2)
Guanosine 3'-diphosphate 5'-triphosphate (2)
2-Hexaprenyl-6-methoxyphenol (2)
Triazolam (2)
2-Dodecylbenzenesulfonic acid (2)
Chlorobenzene (2)
Histidine (2)
Glucosylceramide (d18:1/22:0) (2)
Phenobarbital (2)
Glucosylceramide (2)
3-Indolehydracrylic acid (2)
N-Acetylgalactosamine (2)
Glutarylcarnitine (2)

First Public Date

2026 (3)

Study type

Transcription profiling by array (17)
RNA-seq of coding RNA (4)
High-throughput sequencing (1)
Animal - High-throughput sequencing (1)
Genotyping by array (1)
Other (1)
ChIP-seq (1)
RNA-seq of total RNA (1)

Release Date

2019 (16)
2020 (16)
2021 (14)
2024 (13)
2022 (13)
2023 (12)
2018 (11)
2025 (8)
2017 (8)
2014 (7)
2013 (7)
2012 (7)
2011 (7)
2016 (5)
2015 (5)
2009 (3)
2026 (2)
2010 (2)
2004 (2)
2008 (1)
2007 (1)
2006 (1)

Lab affiliation

Department of Geoscience, University of Calgary, Calgary Ab, Canada (1)
Department of Liver Surgery and Transplantation, Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, China (1)

Tags

xref:PubMed:41498265 (1)

Previous page
1 / 19
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 19
Next page

Sort by:

Relevance

Page size

PON-1 and PON-2 Polymorphisms and PON-1 Paraoxonase Activity in People Living with HIV-1.

Not available

S-EPMC11851513 | biostudies-literature

PON-1 carbamylation is enhanced in HDL of uremia patients.

Not available

S-EPMC9296198 | biostudies-literature

Serial measurements of Paraoxonase-1 (PON-1) activity in horses with experimentally induced endotoxemia.

Not available

S-EPMC7641807 | biostudies-literature

Microarray analysis of the brain in a mouse model of cerebral ischemia/reperfusion injury treated with human paraoxonase 1 against vehicle control

Paraoxonase 1 (PON 1) binds to high-density lipoprotein (HDL) and is responsible for its anti-atherosclerotic effect through its antioxidant activity. This dataset contains gene expression data obtained from a study investigating the effects of human paraoxonase 1 treatment on acute ischemic stroke ...

ORGANISM(S): Mus musculus

2025-06-05 | E-MTAB-14182 | biostudies-arrayexpress

Paraoxonase-1 (PON-1) Arylesterase Activity Levels in Patients with Coronary Artery Disease: A Meta-Analysis.

Not available

S-EPMC8930235 | biostudies-literature

Exploring the Relationship between Canine Paraoxonase-1 (PON-1) Serum Activity and Liver Disease Classified by Clinico-Pathological Evaluation.

Not available

S-EPMC11475043 | biostudies-literature

Circulating Lactonase Activity but Not Protein Level of PON-1 Predicts Adverse Outcomes in Subjects with Chronic Kidney Disease.

Not available

S-EPMC6678354 | biostudies-literature

Association of a polymorphism in PON-1 gene with steroid-induced osteonecrosis of femoral head in Chinese Han population.